Detalles de la búsqueda
1.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med
; 385(25): 2348-2360, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587382
2.
Ongoing Analytical Procedure Performance Verification Using a Risk-Based Approach to Determine Performance Monitoring Requirements.
Anal Chem
; 96(3): 966-979, 2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191128
3.
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
N Engl J Med
; 376(25): 2448-2458, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28530840
4.
Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms.
J Infect Dis
; 218(suppl_5): S553-S564, 2018 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29939318
5.
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting ß2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.
Lancet
; 388(10056): 2115-2127, 2016 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27609408
6.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 388(10056): 2128-2141, 2016 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27609406
7.
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection.
Cell Rep Med
; 4(1): 100882, 2023 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610390
8.
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.
NPJ Vaccines
; 8(1): 36, 2023 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36899062
9.
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months.
J Clin Invest
; 132(18)2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36106642
10.
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.
Front Immunol
; 13: 1062067, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36713413
11.
Effect of Daytime Versus Night-time on Outcome in Patients Undergoing Emergent Neurosurgical Procedures.
J Neurosurg Anesthesiol
; 32(4): 315-322, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32898387
12.
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.
Lancet Respir Med
; 7(1): 46-59, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30416083
Resultados
1 -
12
de 12
1
Próxima >
>>